2024
Practice Advisory for Postoperative Pain Management of Cardiac Surgical Patients: A Report by Society of Cardiovascular Anesthesiologists
Makkad B, Heinke T, Sheriffdeen R, Meng M, Kachulis B, Grant M, Popescu W, Brodt J, Khatib D, Wu C, Kertai M, Bollen B. Practice Advisory for Postoperative Pain Management of Cardiac Surgical Patients: A Report by Society of Cardiovascular Anesthesiologists. Journal Of Cardiothoracic And Vascular Anesthesia 2024, 39: 770-784. PMID: 39855959, DOI: 10.1053/j.jvca.2024.10.014.Peer-Reviewed Original ResearchCardiac surgeryPostoperative pain managementPain managementManagement of cardiac surgical patientsOpioid-related adverse effectsRisk of postoperative cardiopulmonary complicationsFast-track extubationAssociated with serious adverse effectsCardiac surgical patientsPostoperative pain controlPostoperative cardiopulmonary complicationsFascial plane blocksSerious adverse effectsPractice advisoryAdverse effectsPromote early recoverySociety of Cardiovascular AnesthesiologistsNon-pharmacological therapiesPlane blockSevere painCardiopulmonary complicationsMultimodal analgesiaNeurological sequelaePain controlRegional analgesia
2020
Personalized Connectome Mapping to Guide Targeted Therapy and Promote Recovery of Consciousness in the Intensive Care Unit
Edlow B, Barra M, Zhou D, Foulkes A, Snider S, Threlkeld Z, Chakravarty S, Kirsch J, Chan S, Meisler S, Bleck T, Fins J, Giacino J, Hochberg L, Solt K, Brown E, Bodien Y. Personalized Connectome Mapping to Guide Targeted Therapy and Promote Recovery of Consciousness in the Intensive Care Unit. Neurocritical Care 2020, 33: 364-375. PMID: 32794142, PMCID: PMC8336723, DOI: 10.1007/s12028-020-01062-7.Peer-Reviewed Original ResearchConceptsIntensive care unitPromote recovery of consciousnessRecovery of consciousnessIntravenous methylphenidateEarly recovery of consciousnessPromote early recoveryPhase 2aDrug-related adverse eventsCare unitAscending arousal networkEscalating daily dosesHighest tolerated doseAcute severe traumatic brain injuryDose-finding studyOutcome measuresBrain injurySerum half-lifeMaximal serum concentrationPrimary outcome measureWithdrawal of life-sustaining therapyDrug’s pharmacodynamic propertiesSecondary outcome measuresMagnetic resonance imagingOpen-labelPharmacodynamic criteria
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply